Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species
Ľuboš Drgoňa(Comenius University Bratislava), Rosemary A. Barnes(Innsbruck Medical University), Claudie Charbonneau, A. Khachatryan(University of Southern California), Sajjad Haider, Jennifer Stephens(Abt Global (United States)), Michal Kantecki(Pfizer (France))
European Journal of Clinical Microbiology & Infectious Diseases
September 11, 2013
Cited by 130
Related Papers
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
A Randomized, Blinded, Multicenter Trial of Lipid-Associated Amphotericin B Alone versus in Combination with an Antibody-Based Inhibitor of Heat Shock Protein 90 in Patients with Invasive Candidiasis
|Clinical Infectious Diseases|2006|304
Aspergillus PCR: One Step Closer to Standardization
|Journal of Clinical Microbiology|2010|295